Skip to main content
Signal8

ENDONOVO THERAPEUTICS, INC. (ENDV)

Endonovo Therapeutics, Inc., a biotechnology company, specializes in the development, manufacturing, and distribution of non-invasive electroceutical medical devices designed for regenerative medicine applications. The company's primary offering is SofPulse, an advanced non-invasive therapeutic device that employs electroceutical technology. SofPulse is engineered to provide palliative relief for various conditions, including soft tissue injuries, chronic wounds, and post-operative pain and edema. Beyond these applications, Endonovo's electroceutical medical device is also utilized in treating a broad spectrum of other ailments. These include inflammation, various types of wounds, cardiovascular diseases, chronic kidney and liver disorders (such as non-alcoholic steatohepatitis), peripheral artery diseases, and ischemic stroke. Furthermore, its technology is deployed in managing central nervous system disorders like traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and maintains its headquarters in Woodland Hills, California.

Sector: Electromedical & Electrotherapeutic Apparatus

Industry: Biotechnology

Endonovo Therapeutics, Inc. logo

Endonovo Therapeutics, Inc.

OTC:ENDVHealthcare
Mkt Cap$32K
Float240.02M
O/S318.75M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$2.18M
Total Assets$19K
Free Cash Flow-$43K
Debt & Equity
Total Debt$6.91M
Total Equity-$28.87M
Preferred Stock$26
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
  1. 1:1,000Reverse split
    Dec 20, 20191,000 shares → 1
  2. 1:100Reverse split
    May 15, 2014100 shares → 1
Balance Sheet Details
Assets$19K
Liabilities$28.89M
Accounts Receivable$0
Accounts Payable$3.32M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Revenue$0$10K$140K$135K$73K$166K$310K$83K$0$0$4K$24K$23K$31K$48K$61K$60K
YoY Growth--92.8%3.6%85.2%-55.9%-46.5%272.5%----82.4%5.7%-25.1%-36.0%-21.2%1.0%-
Cost of Revenue$0$625K$655K$10K$15K$65K$93K$13K$15K$16K$2K$15K$14K$1.56M$0$0$0
Gross Profit$0-$615K-$515K$125K$58K$100K$217K$70K-$15K-$16K$2K$9K$9K-$1.53M$48K$61K$60K
Gross Margin--6125.6%-366.9%92.6%79.5%60.6%69.9%84.5%--49.3%36.0%38.9%-5000.1%100.0%100.0%100.0%
Research and Development$0$0$0$0$0$3K$153K$274K$115K$0$0$0$0$0$0$0$0
Selling, General, and Administrative$946K$945K$2.4M$2.74M$1.64M$2.36M$3.23M$4.24M$4.6M$5.41M$2.57M$15K$2.44M$1.74M-$26K$20K$280K
Other$0$1.56M$3.05M$647K$648K$651K$647K-$13K$0$0-$2.66M$1.41M$2K-$59K$3K$13K$100K
Total Operating Expenses$946K$945K$2.4M$3.39M$2.28M$3.01M$4.03M$4.23M$4.6M$5.41M$2.5M$2.2M$2.44M$1.77M$141K$33K$380K
Operating Income (EBIT)-$946K-$1.56M-$2.92M-$3.26M-$2.23M-$2.91M-$3.81M-$4.16M-$4.6M-$5.41M-$2.5M-$2.19M-$2.43M-$1.74M-$96K-$69K-$320K
Operating Margin--15532.5%-2081.7%-2411.7%-3045.7%-1756.5%-1228.1%-4995.3%---58569.6%-9057.6%-10607.6%-5697.5%-200.0%-113.2%-533.3%
Interest Expense$1.24M$1.24M$1.28M$1.32M$942K$2.08M$6.09M$5.2M$5.79M$2.39M$1.54M$179K$268K$114K$0$0$0
Interest Income$0$0$0$0$0$0$0$0$0$0$0$0$0$0$2K$9K$0
Other Income (Expense)-$1.23M-$1.24M$9.84M-$15.21M-$878K$2.52M-$13.51M-$2.28M-$6.21M$95K-$4.2M$1.23M-$464K-$172K$2K$0-$10K
Income Before Tax (EBT)-$2.18M-$2.8M$6.92M-$18.47M-$3.1M-$396K-$17.31M-$6.44M-$10.81M-$5.32M-$5.08M-$959K-$2.89M-$1.91M-$93K-$69K-$330K
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$2.58M$0$532$0$800$800$0
Net Income-$2.18M-$2.8M$6.92M-$18.47M-$3.1M-$396K-$17.31M-$6.44M-$10.81M-$5.32M-$5.08M-$959K-$2.89M-$1.91M-$94K-$69K-$330K
Net Income Margin--27853.2%4937.6%-13649.2%-4247.2%-238.6%-5582.4%-7729.5%---119087.9%-3966.2%-12634.5%-6260.6%-197.0%-114.5%-550.0%
Supplementary Data
EPS-0.00-0.010.03-0.13-0.05-0.03-33.56-17.76-0.04-0.05-0.05-0.03-3.96-3.98-2.07-1.53-0.00
Diluted EPS-0.00-0.010.01-0.13-0.05-0.03-33.56-17.76-0.04-0.05-0.05-0.03-3.96-3.98-2.07-1.53-0.00
Weighted Average OS1.10B543.87M276.36M139.21M59.84M12.22M697,305362,465327,507117,40696,84530,28873,05348,13845,34845,34872,014
EBITDA-$946K-$941K$8.85M-$16.51M-$1.51M$2.34M-$10.57M-$589K-$4.59M-$5.4M-$2.55M-$2.18M-$2.61M-$1.71M$0$0-$320K
EBITDA Margin--9373.7%6313.2%-12194.9%-2072.1%1410.6%-3409.1%-706.8%---59786.4%-8992.5%-11411.3%-5576.4%---533.3%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Assets
Current Assets
Cash and Cash Equivalents$12$3$2K$98$86K$13K$19K$379K$90K$56K$41K$988$3K$800$70K$35K$50K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$12$3$2K$98$86K$13K$19K$379K$90K$56K$41K$988$3K$800$70K$35K$50K
Accounts Receivable$0$0$0$0$944$942$23K$3K$0$0$0$0$0$0$1K$95K$180K
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$18K$18K$18K$16K$8K$0$0$0$0$0$0$2K$0$0$0$0$0
Total Current Assets$18K$18K$20K$16K$95K$46K$63K$382K$111K$303K$44K$3K$3K$800$71K$129K$230K
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$2K$6K$7K$1K$16K$32K$43K$58K$65K$2K$3K$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$619K$1.27M$1.91M$2.56M$3.21M$3.85M$4.5M$0$0$0$12K$0$0$0$0
Long-Term Investments$2K$2K$2K$2K$2K$2K$2K$2K$2K$2K$2K$0$12K$12K$0$0$0
Deferred Tax Assets$0$0$0$0$0$2.56M$3.21M$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0-$2K-$2K-$2.56M-$3.21M-$2K-$2K-$2K-$2K$0-$12K-$77K$0-$3K$10K
Total Long-Term Assets$2K$2K$620K$1.27M$1.91M$2.56M$3.21M$3.86M$4.5M$16K$32K$43K$70K$77K$2K$3K$10K
Other Assets-$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$35K$0
Total Assets$19K$19K$640K$1.28M$2.01M$2.61M$3.27M$4.24M$4.61M$319K$76K$46K$74K$78K$73K$168K$240K
Liabilities
Current Liabilities
Accounts Payable$3.32M$3.43M$1.08M$882K$658K$701K$599K$157K$144K$155K$155K$155K$155K$155K$745$2K$0
Short-Term Debt$6.91M$6.87M$7.07M$7.15M$7.18M$6.63M$8.68M$0$4.74M$2.06M$1.52M$1.39M$715K$236K$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$6.42M$5.29M$3.75M$2.25M-$144K$4.57M$3.84M$0$0$0$0$0$0
Other Current Liabilities$13K$12K$11.1M$17.36M-$449K$818K$8.17M$10.83M$8.04M-$2.64M$3.98M$900$0-$155K$690K-$2K$0
Total Current Liabilities$29K$27K$24.67M$33.38M$17.7M$16.83M$23.62M$15.48M$13.41M$8.72M$7.48M$4.55M$4.01M$1.75M$1K$2K$0
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$6.32M$598K$4K$44K$29K$42K$52K$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$80K$80K$80K$80K$80K$155K$155K-$6.17M$155K$155K$155K$155K$155K$155K$0$0$0
Total Long-Term Liabilities$80K$80K$80K$80K$80K$155K$155K$155K$753K$159K$183K$184K$197K$207K$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$28.89M$26.82M$24.75M$33.46M$17.78M$16.98M$23.78M$15.63M$14.16M$8.88M$7.67M$4.74M$4.21M$1.96M$1K$2K$0
Stockholders' Equity
Preferred Stock$26$26$26$26$26$26$26$26$5$0$0$2K$0$0$0$0$0
Common Stock$169K$54K$33K$21K$7K$2K$118$43K$32K$13K$10K$8K$8K$5K$453$453$0
Retained Earnings-$73.21M-$71.03M-$68.23M-$75.12M-$56.44M-$53.34M-$52.93M-$35.62M-$29.18M-$18.37M-$11.37M-$6.29M-$5.33M-$2.44M-$585K-$491K-$420K
Comprehensive Income & Other$0$0-$33K-$2K-$2K-$2K-$2K-$80K-$77K-$62K-$47K-$2K$0$0-$3K-$2K$0
Other Stockholders' Equity$44.16M$44.17M$44.1M$42.92M$40.66M$38.96M$32.43M$24.19M$19.6M$9.8M$3.77M$1.59M$1.19M$554K$657K$657K$660K
Total Equity-$28.87M-$26.8M-$24.11M-$32.18M-$15.77M-$14.37M-$20.5M-$11.39M-$9.55M-$8.56M-$7.59M-$4.69M-$4.13M-$1.88M$72K$166K$240K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$19K$19K$640K$1.28M$2.01M$2.61M$3.27M$4.24M$4.61M$319K$76K$46K$74K$78K$73K$168K$240K
Supplementary Data
Total Debt$6.91M$6.87M$7.07M$7.15M$7.18M$6.63M$6.86M$6.32M$4.74M$2.06M$1.55M$1.42M$757K$288K$0$0$0
Net Debt$7K$7K$7.07M$7.15M$7.1M$6.62M$6.84M$5.95M$4.65M$2.01M$1.5M$1.42M$754K$287K-$70K-$35K-$50K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Operating Activities
Net Income-$2.18M-$2.8M$6.92M-$18.47M-$3.1M-$396K-$17.31M-$6.44M-$10.81M-$5.32M-$5.08M-$959K-$2.89M-$1.91M-$94K-$69K-$330K
Depreciation & Amortization$0$619K$647K$647K$648K$651K$650K$650K$15K$16K$15K$16K$12K$37K$979$964$0
Deferred Income Tax$0$0$0$0-$95K-$5.05M-$195K$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$687K$45K$95K$457K$195K$628K$1.41M$2.36M$729K$34K$482K$244K$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$22K-$19K-$3K$0$0$0$0$300$5K-$1K$0$0
  Inventory$0$0$0$0$758K$819K$1.01M$645K$0$0$0$0$0$0$0$0$0
  Accounts Payable-$5K$2.35M-$479K$269K-$42K$94K$442K$63K$4.73M$4.74M$901K$0$1.8M$1.3M-$1K$2K$0
  Other Working Capital$2.13M-$68K$2.19M$1.74M$1.27M$1.77M$186K$174K-$4.32M-$4.12M$2K$10K$0-$14K$42K$62K$130K
Total Working Capital Change$2.13M$2.28M$1.71M$2.01M$1.22M$1.89M$1.62M$879K$408K$617K$903K$1.39M$1.8M$1.29M$39K$64K$130K
Other Non-Cash Items$7K$0-$9.84M$15.09M$247K$1.71M$12.51M$2.03M$7.4M$2.22M$3.14M-$1.36M$828K$304K$3K$13K$120K
Net Cash from Operating-$43K$100K$122K-$679K-$987K-$742K-$2.54M-$2.88M-$2.99M-$2.46M-$1.02M-$909K-$257K-$285K-$50K$9K-$80K
Investing Activities
Capital Expenditures$0$0$0$0$0$0-$3K-$9K-$3M$0-$4K$0$5K-$64K$0-$166$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$4K$53K$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0-$9K-$3M$0$0$0-$5K$53K$85K-$23K-$60K
Net Cash from Investing$0$0$0$0$0$0-$3K-$9K-$3M$0-$4K$0$4K-$11K$85K-$23K-$60K
Financing Activities
Debt Repaid----$465K-$950K-$608K-$1.86M-$2.28M-$3.91M-$1.31M-$887K-$936K-$256K-$113K---
Common Stock Issuance$0$98K$11K$142K$126K$100K$168K$788K$1.29M$1.24M$139K$0$0$175K$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0-$10K-$14K-$17K-$22K-$105K-$22K$2.01M$1.24M-$12K-$28K$0$0$0$0$0
Net Cash from Financing$43K-$105K-$120K$593K$1.06M$736K$2.18M$3.18M$6.02M$2.48M$1.06M$907K$256K$288K$0$0$0
Forex Effect$0$3K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$9-$2K$2K-$86K$73K-$5K-$360K$289K$35K$14K$40K-$2K$2K-$9K$35K-$14K-$140K
Supplementary Data
Operating Cash Flow-$43K$100K$122K-$679K-$987K-$742K-$2.54M-$2.88M-$2.99M-$2.46M-$1.02M-$909K-$257K-$285K-$50K$9K-$80K
Capital Expenditure$0$3$0$0$4$0-$3K-$9K-$3M$0-$4K$0$5K-$64K$0-$166$0
Free Cash Flow-$43K$100K$122K-$679K-$987K-$742K-$2.54M-$2.89M-$5.99M-$2.46M-$1.02M-$909K-$252K-$349K-$50K$8K-$80K
Cash at Beginning$3$2K$98$86K$13K$19K$379K$90K$56K$41K$988$3K$800$9K$35K$49K$0
Cash at End$12$3$2K$98$86K$13K$19K$379K$90K$56K$41K$988$3K$800$70K$35K-$140K